Business Context and Reporting Period
Company: ILLUMINA, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: July 26, 2016
Reporting Period: Second Quarter ended July 3, 2016
This filing announces financial results for Q2 2016 and provides management commentary regarding operational drivers, specifically sequencing instrument shipments and array performance.
Key Financial Metrics and Performance
- Sequencing Instruments Revenue: Declined 21% year-over-year compared to Q2 2015.
- Sequencing Instrument Shipments: HiSeq and HiSeq X shipments were roughly flat sequentially, meeting management forecasts.
- Non-GAAP EPS (Q2 2016): The company beat its previous guidance range of $0.72 to $0.74 by $0.13.
- GRAIL Investment: The company exchanged common GRAIL shares for preferred GRAIL shares. Beginning in Q3 2016, the company will recognize approximately 50% of GRAIL's losses.
Note: The filing text does not provide specific values for total revenue, net profit, cash flow, operating margins, total debt, or liquidity positions.
Material Changes and Drivers
- Year-Over-Year Decline: The 21% drop in sequencing instrument revenue was driven by a $30 million headwind. This was attributed to a spike in HiSeq 3000 and 4000 shipments in Q2 2015, which was the first full quarter of product availability for those models.
- Sequential Performance: Instrument shipments were flat sequentially, aligning with expectations set during the Q1 2016 earnings call.
- Array Performance: Strong Q1 2016 array orders supported the company's total revenue growth guidance.
Guidance, Outlook, and Management Commentary
- Fiscal 2016 Revenue Growth: Maintained guidance of 12% revenue growth for 2016 compared to 2015.
- Fiscal 2016 Non-GAAP EPS: Guidance increased to a range of $3.48 to $3.58 (previously $3.35 to $3.45). This increase is fully driven by the $0.13 beat in Q2 2016 non-GAAP EPS.
- Second Half 2016 Outlook:
- HiSeq X: Management expects to ship the backlog built in the first half, resulting in quarterly shipments in excess of 30 units in both Q3 and Q4 2016.
- HiSeq Instruments: A solid Americas pipeline is expected to drive higher shipments in Q4 2016.
- Contingencies: The recognition of GRAIL losses is now expected to be approximately 50% in the second half of the year, consistent with prior guidance assumptions.
Investor Verification Checklist
- Verify the specific total revenue and net income figures for Q2 2016 in the full press release or 10-Q filing, as they are not detailed in this 8-K text.
- Confirm the exact number of HiSeq X units shipped in Q2 2016 to validate the "roughly flat" sequential claim.
- Review the detailed breakdown of the $30 million year-over-year headwind to understand the specific mix of HiSeq 3000/4000 impact.
- Monitor Q3 2016 results to confirm the realization of the >30 unit HiSeq X shipment forecast.
- Assess the impact of the GRAIL share exchange on future consolidated loss recognition.